Literature DB >> 6741874

The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies.

K C Gatter, C Alcock, A Heryet, K A Pulford, E Heyderman, J Taylor-Papadimitriou, H Stein, D Y Mason.   

Abstract

The value of immunohistological labeling with a panel of monoclonal antibodies in the diagnosis of routinely processed surgical biopsies has been assessed. The cases examined consisted of an unselected series of tumor biopsies referred during a 12-month period because of doubt as to the nature of the neoplasm and are representative of the type of diagnostic problem regularly encountered in routine surgical pathology. In 30 of the 38 cases studied, reactivity with monoclonal antileukocyte antibody (and nonreactivity with monoclonal antiepithelial antibodies) indicated that the tumor was a lymphoma. Seven of the remaining eight cases gave the reverse reaction pattern and therefore were classified as carcinomas, while one biopsy was unreactive with all antibodies. Review of the clinical details in each case showed that the clinical management in several instances was influenced by establishing the correct diagnosis and it therefore is suggested that immunohistologic examination should be used more widely in the study of tumors that give rise to diagnostic difficulty.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6741874     DOI: 10.1093/ajcp/82.1.33

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

1.  Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.

Authors:  G Delsol; T Al Saati; K C Gatter; J Gerdes; R Schwarting; P Caveriviere; F Rigal-Huguet; A Robert; H Stein; D Y Mason
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  Lymphoid and epithelial markers in small cell anaplastic thyroid tumours.

Authors:  A D Burt; D J Kerr; I L Brown; P Boyle
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

3.  Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.

Authors:  R N Poston; Y S Sidhu
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

4.  Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.

Authors:  T Kawai; S D Greenberg; L D Truong; C A Mattioli; M Klima; J L Titus
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium.

Authors:  K Lindberg; J G Rheinwald
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

6.  Undifferentiated sarcoma of the sellar region.

Authors:  Branavan Manoranjan; Luis V Syro; Bernd W Scheithauer; Leon D Ortiz; Eva Horvath; Fateme Salehi; Kalman Kovacs; Michael D Cusimano
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

7.  Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues.

Authors:  M J Goddard; B Wilson; J W Grant
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

8.  An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.

Authors:  K C Gatter; E Ralfkiaer; J Skinner; D Brown; A Heryet; K A Pulford; K Hou-Jensen; D Y Mason
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411

9.  Immunohistochemical markers in the identification of metastatic breast cancer.

Authors:  P C de Almeida; C B Pestana
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Immunohistochemical analysis of undifferentiated and poorly-differentiated head and neck malignancies at a tertiary hospital in Nigeria.

Authors:  Akinyele O Adisa; Abideen O Oluwasola; Bukola F Adeyemi; Bamidele Kolude; Effiong Eu Akang; Jonathan O Lawoyin
Journal:  Head Neck Oncol       Date:  2010-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.